Safety and tolerability of elubaquine (bulaquine, CDRI 80/53) for treatment of Plasmodium vivax malaria in Thailand

We conducted a study to compare the safety and tolerability of anti-relapse drugs elubaquine and primaquine against Plasmodium vivax malaria. After standard therapy with chloroquine, 30 mg/kg given over 3 days, 141 patients with P. vivax infection were randomized to receive primaquine or elubaquine....

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Krudsood, Srivicha, Wilairatana, Polrat, Tangpukdee, Noppadon, Chalermrut, Kobsiri, Srivilairit, Siripun, Thanachartwet, Vipa, Muangnoicharoen, Sant, Luplertlop, Natthanej, Brittenham, Gary M., Looareesuwan, Sornchai
Format: Artigo
Idioma:Inglês
Publicat: The Korean Society for Parasitology 2006
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2532664/
https://ncbi.nlm.nih.gov/pubmed/16969059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3347/kjp.2006.44.3.221
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars